September 2017 Current Abstracts
The following is a monthly list of selected journal articles and reports on tobacco topics. Please note that this list is not all-inclusive. We try to choose titles of interest to our tobacco control network, but we realize that there are many relevant articles that are not listed.
Full text is available where indicated, otherwise, a fee may be required.
A study by OTRU describes the preparations of the tobacco industry in advance of the menthol ban in Ontario.
Schwartz R, Chaiton M, Borland T, Diemert L. Tobacco industry tactics in preparing for menthol ban. Tobacco Control 2017 Sep 8 [Epub ahead of print].
A Canadian study found that smoking susceptibility was linked to youth e-cigarette use. Chapman, in an editorial in BMJ, heaps scorn on the claim that Philip Morris International wants to stop smoking. Filippidis and colleagues show that the presence of discount cigarettes is associated with increased infant mortality.
Azagba S, Baskerville NB, Foley K. Susceptibility to cigarette smoking among middle and high school e-cigarette users in Canada. Preventive Medicine 2017 Oct;103:14-9.
Harm Reduction—Tobacco Industry
Chapman S. Tobacco giant wants to eliminate smoking. British Medical Journal 2017 Sep 26;358:j4443.
Filippidis FT, Laverty AA, Hone T, Been J V, Millett C. Association of cigarette price differentials with infant mortality in 23 European Union countries. JAMA Pediatrics 2017 Sep 18 [Epub ahead of print].
van den Brand FA, Nagelhout GE, Reda AA, Winkens B, Evers SMAA, Kotz D, et al. Healthcare financing systems for increasing the use of tobacco dependence treatment. Cochrane Database of Systematic Reviews 2017 Sep 12;9:CD004305 [Epub ahead of print].
Smoking Cessation—Heart Disease
Chehab OM, Dakik HA. Interventions for smoking cessation in patients admitted with Acute Coronary Syndrome: review. Postgraduate Medical Journal 2017 Sep 23 [Epub ahead of print].
Taylor GMJ, Dalili MN, Semwal M, Civljak M, Sheikh A, Car J. Internet-based interventions for smoking cessation. Cochrane Database of Systematic Reviews 2017 Sep 4;9:CD007078 [Epub ahead of print].
Schuit E, Panagiotou OA, Munafò MR, Bennett DA, Bergen AW, David SP. Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database of Systematic Reviews 2017 Sep 8;9:CD011823 [Epub ahead of print].
Smoking Cessation—Substance Users
Gentry S, Craig J, Holland R, Notley C. Smoking cessation for substance misusers: A systematic review of qualitative studies on participant and provider beliefs and perceptions. Drug and Alcohol Dependence 2017 Nov 1;180:178-92 [Epub ahead of print].
Recent Work by Canadian Researchers
Tulsieram KL, Rinaldi S, Shelley JJ. Recommendations: will the Tobacco and Vaping Products Act go far enough? Canadian Journal of Public Health 2017 Sep 14;108(3):e328-30.
Health Effects—Paternal Smoking
Beal MA, Yauk CL, Marchetti F. From sperm to offspring: assessing the heritable genetic consequences of paternal smoking and potential public health impacts. Mutation Research/Reviews in Mutation Research 2017 Jul;773:26-50.
Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, et al. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences. Addiction 2017 Sep 16 [Epub ahead of print].
Wellman RJ, O’Loughlin EK, Dugas EN, Montreuil A, Dutczak H, O’Loughlin J. Reasons for quitting smoking in young adult cigarette smokers. Addictive Behaviors 2017 Sep 20;77:28-33 [Epub ahead of print].
Gagné T. Estimation of smoking prevalence in Canada: implications of survey characteristics in the CCHS and CTUMS/CTADS. Canadian Journal of Public Health 2017 Sep 14;108(3):e331-4.